Multidimensional Study of Dyspnea at Rest, During Exertion, Self-induced Through a Virtual Reality Scenario, and Its Placebo Effect in Patients With COPD and Control Subjects.

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Deusto

About this trial

This quasi-experimental laboratory study aims to describe and compare the multidimensional experience of dyspnea at rest and during exertion in patients with chronic obstructive pulmonary disease (COPD) and healthy controls. The study integrates neurophysiological, somatosensory, and psychological assessments, including prefrontal cortex activity (fNIRS), quantitative sensory testing (QST), and immersive virtual reality (VR) scenarios.

Additionally, the study evaluates the modulation of dyspnea perception through expectation mechanisms and placebo intervention using high-flow nasal cannula (HFNC). The ultimate goal is to better understand the multidimensional and neurocognitive mechanisms underlying dyspnea.

Eligibility criteria

Qualifiers

Diagnosed COPD (FEV1/FVC < 0.7 post-bronchodilator)

GOLD stage 2-4

Clinically stable

Signed informed consent

Disqualifiers

Severe cardiac, neurological, or psychiatric disease

Other respiratory diseases

Recent exacerbation

Use of ventilatory support (except CPAP)

Trial design

Treatments tested in this trial

  • Induced Dyspnea via Inspiratory Muscle Loading
  • Virtual Reality Sensory Immersion
  • Placebo and Active Conditions

Treatment groups

80 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Deusto

Lead sponsor

Osakidetza

Collaborator